A 62-year-old client with COPD continues to have frequent ex…

A 62-year-old client with COPD continues to have frequent exacerbations despite treatment with a long-acting beta-2 agonist (LABA) and an inhaled corticosteroid (ICS). The healthcare provider considers adding another medication to improve control. Which class of drugs would be most appropriate to add to the regimen?